{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:04:19Z","timestamp":1773273859286,"version":"3.50.1"},"reference-count":104,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1080\/13543784.2026.2618980","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:31:52Z","timestamp":1769013112000},"page":"99-113","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Advances of next-generation STAMP inhibitors in chronic myeloid leukemia"],"prefix":"10.1080","volume":"35","author":[{"given":"Alessandro","family":"Costa","sequence":"first","affiliation":[{"name":"University of Cagliari","place":["Cagliari, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Breccia","sequence":"additional","affiliation":[{"name":"Az. Policlinico Umberto I-Sapienza University","place":["Rome, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.2866"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2023.03.004"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.73"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001329"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02187-w"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3071"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.02.025"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221531"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.09.011"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739086"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178790"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35832"},{"key":"e_1_3_4_17_1","unstructured":"FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia | FDA [Internet]. [cited 2025 Sep 2]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-asciminib-newly-diagnosed-chronic-myeloid-leukemia"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2025.2464494"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2024.2331778"},{"key":"e_1_3_4_20_1","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell PC","year":"1960","unstructured":"Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960;25:85\u2013109.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/243290a0"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8438166"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.10.3897.bloodjournal86103897"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(03)00274-0"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601912462126"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb500696t"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00073"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36956-5"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.166"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029828"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2010.01054.x"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm301581y"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2019.08.007"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.026633"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00663-2"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(03)00194-6"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(03)00191-0"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-020-00766-w"},{"issue":"15","key":"e_1_3_4_39_1","first-page":"4236","article-title":"Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)","volume":"62","author":"Nagar B","year":"2002","unstructured":"Nagar B, Bornmann WG, Pellicena P, et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). Cancer Res. 2002;62(15):4236\u20134243.","journal-title":"Cancer Res"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio760"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08675"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106458"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.047191"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015929"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01040"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21702"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140968"},{"key":"e_1_3_4_48_1","volume-title":"Scemblix (asciminib) tablets, for oral use: highlights of prescribing information","author":"Novartis Pharmaceuticals Corporation","year":"2021","unstructured":"Novartis Pharmaceuticals Corporation. Scemblix (asciminib) tablets, for oral use: highlights of prescribing information. U.S. Food & Drug Administration; 2021. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215358s000Orig2lbl.pdf"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902328"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01860-w"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009984"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-186854"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-200017"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2699"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-168228"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04562-5"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04932-6"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70101"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400858"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029210"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024657"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-201218"},{"key":"e_1_3_4_63_1","unstructured":"Hochhaus A Br\u00fcmmendorf TH Mahon FX et al. Asciminib shows superior tolerability vs nilotinib in newly-diagnosed chronic-phase chronic myeloid leukemia: primary end-point results of the Phase 3b ASC4START trial. EHA 2025 Congress Abstract S166. Available from: https:\/\/library.ehaweb.org\/eha\/2025\/eha2025-congress\/4159243\/andreas.hochhaus.asciminib.28asc29.shows.superior.tolerability.vs.nilotinib.html?f="},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02592-9"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.264"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24393"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2019.03.018"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022538"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102238"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.08.004"},{"issue":"9","key":"e_1_3_4_71_1","first-page":"4470","article-title":"Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1\n                  T315I-compound mutations","volume":"11","author":"Gleixner KV","year":"2021","unstructured":"Gleixner KV, Filik Y, Berger D, et al. Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1T315I-compound mutations. Am J Cancer Res. 2021;11(9):4470\u20134484.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-181391"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028539"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024026312"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.07.006"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2022.128577"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-205300"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-902"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(23)01158-8"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(25)01942-1"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-182343"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2025.100109"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2152-2650(24)01311-9"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-204153"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-901"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000974700.92818.27"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000447"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041045"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19269"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-201022"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.080234"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02278-8"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-209537"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01829-9"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000967536.34543.a6"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03881.x"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(03)01050-7"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-003-0829-4"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-140665"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.045260"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/637059"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024838"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01378-7"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.farma.2024.03.008"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27477"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-2835"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2026.2618980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:35:40Z","timestamp":1773221740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2026.2618980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1080\/13543784.2026.2618980"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2026.2618980","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}